These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2560378)

  • 1. Effect of sodium bicarbonate and sodium starch glycolate on the in vivo disintegration of hard gelatin capsules--a radiological study in the dog.
    Marvola M; Hannula AM; Ojantakanen S; Westermarck E; Rajamäki M
    Acta Pharm Nord; 1989; 1(6):355-62. PubMed ID: 2560378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the physicochemical properties and concentration of native and modified potato starch on the release of a hydrophobic drug from hard gelatin capsules.
    De Beukelaer P; Van Ooteghem M; Ludwig A
    J Pharm Belg; 1991; 46(4):252-60. PubMed ID: 1795214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional assessment of four types of disintegrants and their effect on the spironolactone release properties.
    Rojas J; Guisao S; Ruge V
    AAPS PharmSciTech; 2012 Dec; 13(4):1054-62. PubMed ID: 22899380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Simple and Inexpensive Image Analysis Technique to Study the Effect of Disintegrants Concentration and Diluents Type on Disintegration.
    Berardi A; Bisharat L; Blaibleh A; Pavoni L; Cespi M
    J Pharm Sci; 2018 Oct; 107(10):2643-2652. PubMed ID: 29935295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of cassava starch in the formulation of gelatin capsules].
    Nduele M; Ludwig A; Van Ooteghem M
    J Pharm Belg; 1993; 48(5):325-34. PubMed ID: 8120785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.
    Zaheer K; Langguth P
    Drug Dev Ind Pharm; 2018 Mar; 44(3):444-451. PubMed ID: 29098885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionality of disintegrants and their mixtures in enabling fast disintegration of tablets by a quality by design approach.
    Desai PM; Er PX; Liew CV; Heng PW
    AAPS PharmSciTech; 2014 Oct; 15(5):1093-104. PubMed ID: 24848762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The release of a model low-dose drug (riboflavine) from hard gelatin capsule formulations.
    Stewart AG; Grant DJ; Newton JM
    J Pharm Pharmacol; 1979 Jan; 31(1):1-6. PubMed ID: 32357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement by super disintegrants of the properties of tablets containing lactose, prepared by wet granulation.
    van Kamp HV; Bolhuis GK; Lerk CF
    Pharm Weekbl Sci; 1983 Aug; 5(4):165-71. PubMed ID: 6622211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Phosphorus Cross-Linking to Hydration Rates in Sodium Starch Glycolate Tablet Disintegrants Using MRI.
    Abraham A; Olusanmi D; Ilott AJ; Good D; Murphy D; Mcnamara D; Jerschow A; Mantri RV
    J Pharm Sci; 2016 Jun; 105(6):1907-1913. PubMed ID: 27155767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The filling of molten and thixotropic formulations into hard gelatin capsules.
    Walker SE; Ganley JA; Bedford K; Eaves T
    J Pharm Pharmacol; 1980 Jun; 32(6):389-93. PubMed ID: 6106669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pH regulators used as additives on the bioavailability of ibuprofen from hard gelatin capsules.
    Hannula AM; Marvola M; Rajamaeki M; Ojantakanen S
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():221-7. PubMed ID: 1820883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules.
    Gohil UC; Podczeck F; Turnbull N
    Int J Pharm; 2004 Nov; 285(1-2):51-63. PubMed ID: 15488679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of polymer-bound fast-dissolving metformin buccal film with disintegrants.
    Haque SE; Sheela A
    Int J Nanomedicine; 2015; 10 Suppl 1(Suppl 1):199-205. PubMed ID: 26491321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: a comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules.
    Tuleu C; Khela MK; Evans DF; Jones BE; Nagata S; Basit AW
    Eur J Pharm Sci; 2007 Mar; 30(3-4):251-5. PubMed ID: 17188473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of tablet disintegrants: impact of storage conditions and relative tablet density.
    Quodbach J; Kleinebudde P
    Pharm Dev Technol; 2015; 20(6):762-8. PubMed ID: 24848093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J
    Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting zero-order release kinetics of porous gelatin capsules.
    Chen GL; Hao WH
    Drug Dev Ind Pharm; 1998 Jun; 24(6):557-62. PubMed ID: 9876623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disintegrant Selection in Hydrophobic Tablet Formulations.
    Bauhuber S; Warnke G; Berardi A
    J Pharm Sci; 2021 May; 110(5):2028-2037. PubMed ID: 33181185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.